Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2018-05-02 to 2023-09-06
Current total value of award: $655.32
Description: 8505005015!HEPATITIS B VIRUS V